27
Participants
Start Date
August 22, 2025
Primary Completion Date
April 30, 2026
Study Completion Date
December 31, 2027
Selinexor 40 mg
Patients will receive 40mg of oral SEL, weekly, beginning after they have completed step-up dosing and are 5 (± 2) days out from administration of the first full treatment dose of bispecific antibody therapy for 12 months or until disease progression.
RECRUITING
Duke University Health System, Durham
Lead Sponsor
Duke University
OTHER